Incidence and Risk Factors for Blood Transfusion in Total Joint Arthroplasty: Analysis of a Statewide Database

Journal of Arthroplasty

Volumn 32, Issue 9, 2017, Pages 2684-2687.e1

  Slover, James ^a   Lavery, Jessica A ^a   Schwarzkopf, Ran ^a   Iorio, Richard ^a   Bosco, Joseph ^a   Gold, Heather T ^a,b  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

blood transfusion; total hip arthroplasty; total knee arthroplasty

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL EVALUATION; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HIP ARTHROPLASTY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR; TOTAL HIP PROSTHESIS; TOTAL KNEE ARTHROPLASTY; VERY ELDERLY; CALIFORNIA; FACTUAL DATABASE; HIP REPLACEMENT; JOINT; KNEE REPLACEMENT; MULTIVARIATE ANALYSIS; ODDS RATIO; OPERATIVE BLOOD LOSS; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CALIFORNIA; DATABASES, FACTUAL; FEMALE; HUMANS; JOINTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES;

EID: 85020099388     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2017.04.048     Document Type: Article

References (18)

1. Kurtz, S., Ong, K., Lau, E., Mowat, F., Halpern, M., Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89 (2007), 780–785.
2. Blumberg, N., Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 45:2 Suppl (2005), 33S–39S.
3. Clifford, L., Jia, Q., Yadav, H., Subramanian, A., Wilson, G.A., Murphy, S.P., et al. Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology 122 (2015), 21–28.
4. Peters, A.L., Vlaar, A.P., Redefining transfusion-related acute lung injury: don't throw the baby out with the bathwater. Transfusion 56 (2016), 2384–2388.
5. Goyal, N., Chen, D.B., Harris, I.A., Rowden, N., Kirsh, G., MacDessi, S.J., Clinical and financial benefits of intra-articular tranexamic acid in total knee arthroplasty. J Orthop Surg 24 (2016), 3–6.
6. So-Osman, C., Nelissen, R.G., Koopman-van Gemert, A.W., Kluyver, E., Poll, R.G., Onstenk, R., et al. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl. Anesthesiology 120 (2014), 852–860.
7. Yi, Z., Bin, S., Jing, Y., Zongke, Z., Pengde, K., Fuxing, P., Tranexamic acid administration in primary total hip arthroplasty: a randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J Bone Joint Surg Am 98 (2016), 983–991.
8. Eindhoven, G.B., Diercks, R.L., Richardson, F.J., van Raaij, J.J., Hagenaars, J.A., van Horn, J.R., et al. Adjusted transfusion triggers improve transfusion practice in orthopaedic surgery. Transfus Med 15 (2005), 13–18.
9. HCUP Databases, Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality. 2006–2009.
10. Hart, A., Khalil, J.A., Carli, A., Huk, O., Zukor, D., Antoniou, J., Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am 96 (2014), 1945–1951.
11. Harris, R.N., Moskal, J.T., Capps, S.G., Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. J Arthroplasty 30 (2015), 192–195.
12. Zhu, Y., Zhang, F., Chen, W., Liu, S., Zhang, Q., Zhang, Y., Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. J Hosp Infect 89 (2015), 82–89.
13. Hendrickson, J.E., Roubinian, N.H., Chowdhury, D., Brambilla, D., Murphy, E.L., Wu, Y., et al., National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study (REDS-III). Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication. Transfusion 56 (2016), 2587–2596.
14. Haughom, B.D., Schairer, W.W., Nwachukwu, B.U., Hellman, M.D., Levine, B.R., Does neuraxial anesthesia decrease transfusion rates following total hip arthroplasty?. J Arthroplasty 30:9 Suppl (2015), 116–120.
15. Suarez, J.C., Slotkin, E.M., Szubski, C.R., Barsoum, W.K., Patel, P.D., Prospective, randomized trial to evaluate efficacy of a bipolar sealer in direct anterior approach total hip arthroplasty. J Arthroplasty 30 (2015), 1953–1958.
16. Bhutta, M.A., Ajwani, S.H., Shepard, G.J., Ryan, W.G., Reduced blood loss and transfusion rates: additional benefits of local infiltration anaesthesia in knee arthroplasty patients. J Arthroplasty 30 (2015), 2034–2037.
17. Rodriguez-Merchan, E.C., Ortega-Andreu, M., Padilla-Eguiluz, N.G., Gomez-Cardero, P., Martinez-Lloreda, A., Gomez-Barrena, E., Low-volume formulation of intra-articular tranexamic acid, 25-ml tranexamic acid (2.5 g) plus 20-ml saline, is effective in decreasing blood transfusion rate in primary total knee replacement even without preoperative haemoglobin optimization. Blood Coagul Fibrinolysis 27 (2016), 660–666.
18. Frew, N., Alexander, D., Hood, J., Acornley, A., Impact of a blood management protocol on transfusion rates and outcomes following total hip and knee arthroplasty. Ann R Coll Surg Engl 98 (2016), 380–386.